Miscarriage in the first trimester according to the presence or absence of the progesterone-induced blocking factor at three to five weeks from conception in progesterone supplemented women

Clinical and Experimental Obstetrics and Gynecology

Volumn 32, Issue 1, 2005, Pages 13-14

  Check, J H ^a,b   Levin, E ^a   Bollendorf, A ^a   Locuniak, J ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b NONE   (United States)

Author keywords

Immonomodulatory protein; Miscarriage; Progesterone

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; HORMONE; PROGESTERONE; PROGESTERONE INDUCED BLOCKING FACTOR; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CASE REPORT; CONCEPTION; FEMALE; FIRST TRIMESTER PREGNANCY; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOMODULATION; LYMPHOCYTE; PROTEIN EXPRESSION; SPONTANEOUS ABORTION; SUPPOSITORY; ULTRASOUND;

ABORTION, SPONTANEOUS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, FIRST; PROGESTERONE; SUPPOSITORIES;

EID: 17444407531     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Szekeres-Bartho J., Barakonyi A., Par G., Polgar B., Palkovics T., Szereday L.: "Progesterone as an immunomodulatory molecule". Int. Immunopharmacol., 2001, 1, 1037.
2. Szekeres-Bartho J., Faust Zs., Varga P.: "The expression of a progesterone-induced immunomodulatory protein in pregnancy lymphocytes". Am. J. Reprod. Immunol., 1995, 34, 342.
3. Check J.H., Arwitz M., Gross J., Peymer M., Szekeres-Bartho J.: "Lymphocyte immunotherapy (LI) increases serum levels of progesterone induced blocking factor (PIBF)". Am. J. Reprod. Immunol., 1997, 37, 17.
4. Check J.H., Tarquini P., Gandy P., Lauer C.: "A randomized study comparing the efficacy of reducing the spontaneous abortion rate following lymphocyte and progesterone treatment versus progesterone alone in primary habitual aborters". Gynecol. Obstet. Invest., 1995, 39, 257.